Cardiac events are a common cause of peri-operative morbidity. Cardiopulmonary exercise testing can objectively assess risk, but it does not quantify myocardial ischaemia. With appropriate dietary preparation to suppress basal myocardial glucose uptake, positron emission tomography with 18 F-fluorodeoxyglucose can identify post-ischaemic myocardium, providing an attractive complement to exercise testing. We aimed to investigate the feasibility of this diagnostic algorithm. Patients referred for cardiopulmonary exercise testing before major cancer surgery were prospectively recruited. Exercise testing and positron emission tomography imaging were performed after a high fat-low carbohydrate meal. Protocol feasibility (primary end-point) included compliance with pre-test diet instructions and the completion of tests. Stress myocardial perfusion imaging was performed if either exercise testing or positron emission tomography was equivocal or positive for ischaemia. We recorded cardiac complications for 30 postoperative days. We enrolled 26 participants, 20 of whom completed protocol. Twenty-one participants proceeded to surgery: myocardial injury or infarction was diagnosed in three participants, two of whom had positive or equivocal positron emission tomography but negative myocardial perfusion imaging. We have shown that pre-operative cardiac positron emission tomography after cardiopulmonary exercise testing is feasible; protocol deviations were minor and did not affect image quality. Our findings warrant further investigation to compare the diagnostic utility of cardiac positron emission tomography imaging with standard pre-operative stress tests.
Introduction
Each year over 10 million patients have postoperative cardiac complications [1] . Accurate cardiac risk prediction may reduce complications through targeted peri-operative management. Cardiac stress tests inadequately predict complications after non-cardiac non-vascular surgery [2] .
Cardiopulmonary exercise testing is the standard method to objectively quantify functional capacity. It is used to assess patients' ability to meet the metabolic demands of major surgery and to predict postoperative morbidity and mortality, including from cardiac disease [3] . Pre-operative tests that can identify the site and severity of stress-induced myocardial ischaemia might complement cardiopulmonary exercise tests and increase the precision of predictions.
Cardiac positron emission tomography identifies ischaemic myocardium through its preferential metabolism of the radiolabeled glucose analogue 18 F-fluorodeoxyglucose [4] . A significant proportion of peri-operative cardiac events are associated with myocardial metabolic demand exceeding supply [5, 6] . Positron emission tomography may detect stress-induced ischaemia more sensitively than myocardial perfusion imaging [7, 8] . Technical advantages include superior spatial resolution acquired more rapidly with less radiation [9] .
The normal heart metabolises free fatty acids unless stimulated by insulin [10] . Accurate identification of myocardial ischaemia with positron emission tomography depends on suppressing basal myocardial glucose uptake, which can be achieved by eating a fatty meal containing little carbohydrates [11] . We conducted a prospective study to assess the feasibility of incorporating cardiac positron emission tomography with pre-operative cardiopulmonary exercise testing.
Methods
The Peter MacCallum Cancer Centre Human Research Ethics Committee approved this study (Fig. 1) . We recruited adults from July 2014 to February 2016 for whom cardiopulmonary exercise testing was indicated before intrathoracic, intraperitoneal or head and neck cancer resection or free-flap formation. The first 10 participants scored no more than 1 on the Revised Cardiac Risk Index and the subsequent 20 participants scored at least 2. We did not study patients unable to consent or those with insulin-dependent diabetes and women who were pregnant or breastfeeding. Participants provided written informed consent.
To promote myocardial fluorodeoxyglucose uptake after exercise, participants ate a fatty dinner and breakfast with little carbohydrates and drank a fatty drink 4-6 h before testing ('Calogen', Nutricia Australia, North Ryde, NSW, Australia), while beta-blockers were withheld for the preceding 48 h [15, 16] . Before exercise, we One of two experienced anaesthetic consultants supervised standard cardiopulmonary exercise testing [17] . Breath-by-breath gas exchange analysis determined peak volitional oxygen consumption during ramped cycle ergometry, with continuous 12-lead ECG monitoring, after which we injected intravenously 3.6 MBq.kg 
Results
We discontinued recruitment after 26 participants due to insufficient funds and time (Fig. 2) . The full protocol was completed by 20 out of 26 participants: 23 ate the fatty (Table 1) .
Seven beta-blocked participants discontinued the drug for at least 48 h. There were no adverse events with fluorodeoxyglucose injection, given within 15 min of exercise in all 24 participants, in 23 of whom positron emission tomography was completed within 120 min of injection. Myocardial ischaemia on cardiopulmonary exercise tests and positron emission tomography (Fig. 3 ) are detailed in Table 2 , as well as myocardial perfusion imaging in nine participants, and postoperative complications in 21
patients who proceeded to surgery. Background myocardial fluorodeoxyglucose uptake was completely suppressed in 20 out of 24 participants: three participants had low-grade papillary muscle uptake and one had low-grade diffuse left ventricular uptake. All participants had normal troponin 
Discussion
We have shown that cardiac positron emission tomography can be incorporated into a pre-operative cardiopulmonary exercise service, with three-quarters of participants completing the protocol. Positron emission tomography detects metabolic ischaemia, rather than the traditional assessments of perfusion or contractility and it might augment risk calculated from cardiopulmonary exercise testing [16] . It may also detect supply-demand imbalance in conditions such as hypertrophic cardiomyopathy [17] and coronary microvascular dysfunction [18] .
The incomplete suppression of background myocardial fluorodeoxyglucose uptake in four participants was consistent with other studies [19] [20] [21] [22] . Diffuse uptake may indicate inadequate dietary preparation, although the participant complied with the protocol and had normal fasting blood glucose [23] . Focal papillary muscle fluorodeoxyglucose uptake in three participants might be a normal physiological variant [12, 13] .
Our study has several limitations. We relied on patientreported dietary intake to assess dietary compliance.
However, all fasting blood glucose levels were within acceptable limits and the average resting respiratory exchange ratio of 0.79 is compatible with the prescribed diet and the reliable interpretation of cardiopulmonary exercise [24] . We did not perform myocardial perfusion imaging in all participants as we were concerned about unwarranted radiation. We did not conceal patient characteristics from investigators who reported positron emission tomograms and those who reported postoperative outcomes.
Further research may determine whether cardiac positron emission tomography can improve the prediction of postoperative outcomes and the thresholds for prognostically significant uptake.
